Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

COMPASS PATHFINDER LIMITED

Home Clinical Trial Sponsors and OrganizationsCOMPASS PATHFINDER LIMITED

COMPASS PATHFINDER LIMITED

3rd Floor, Altrincham, United Kingdom

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

12

8 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

10

83.3%

Phase 2

1

8.3%

Phase 3

1

8.3%

Trial Status Distribution

Active, not recruiting

8

66.7%

Completed

1

8.3%

Recruiting

3

25.0%

Clinical Trials

Trials sponsored by this organization (12)

A study in healthy male volunteers to investigate how the test medicine COMP360 [14C]-psilocybin is taken up, broken down and removed from the body

Active, not recruiting

Sep 20246 participants

A Phase III study to investigate two initial administrations of COMP360 in treatment-resistant depressio

Jun 2023556 participants

A study in healthy volunteers to look at how the test medicine, COMP360, is taken up by the body when given as two different strength capsules

Active, not recruiting

Aug 202214 participants

Efficacy and safety of COMP360 psilocybin therapy in anorexia nervosa: a proof-of-concept study

May 202260 participants

The safety and efficacy of psilocybin as an adjunctive therapy in participants with treatment-resistant depressio

Active, not recruiting

Oct 201920 participants

The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depressio

Active, not recruiting

Jul 2018216 participants

The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depressio

Active, not recruiting

Jun 2018216 participants

The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depressio

Active, not recruiting

Dec 2017216 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials12
Approvals
News

Back to Organizations